Comparison of BD Surepath and ThinPrep Pap Systems in the Processing of Mucus-Rich Specimens
|
|
- Clinton Banks
- 5 years ago
- Views:
Transcription
1 Original Article Comparison of BD Surepath and ThinPrep Pap Systems in the Processing of Mucus-Rich Specimens Shelly Kenyon, MS, CT 1 ; Brenda J. Sweeney, MS, SCT 1 ; James Happel, BS, DLM, HTL 1 ; Gloria E. Marchilli, MS, SCT 2 ; Barbara Weinstein, MD 2 ; and Douglas Schneider, MD 1 BACKGROUND: Excessive mucus, as well as blood and inflammation, can be problematic in the processing and screening of liquid-based cervical Pap preparations by interfering in the process of cell retrieval onto specimen filters or slides. This study compares the capacity of the BD SurePath and ThinPrep liquid-based Papanicolaou (Pap) tests to handle mucus-laden specimens. METHODS: A 100 ll volume of pooled cervical epithelial cells was added to BD SurePath and ThinPrep liquid Pap test vials. Aliquots of cervical mucus that had been collected and pooled from previously processed mucus-rich Pap specimens were added to each series of test vials in amounts of 250 ll, 500 ll, 1000 ll, and 2000 ll. The vials were then routinely processed on their respective instruments and the test slides evaluated for cellularity of the squamous cell component. RESULTS: The BD SurePath test specimens showed no reduction of the squamous cell component resulting from the addition of any of the aliquots of mucus. The ThinPrep test specimens showed a marked loss of cellularity upon the addition of the first aliquot of mucus, with large areas of the filters showing nearly complete absence of squamous cells. CONCLUSIONS: Excessive mucus remains a potentially limiting factor in the ThinPrep Pap system. This appears to be the result of direct obstruction of the filtration membrane causing a markedly diminished retrieval of squamous epithelial cells and potentially impacting disease detection. The BD SurePath system, conversely, manages mucus by a cell enrichment process, which results in undiminished cell recovery as observed in this study s test conditions. Cancer (Cancer Cytopathol) 2010;118: VC 2010 American Cancer Society. KEY WORDS: Pap test, liquid-based cytology, BD SurePath, ThinPrep, Papanicolaou smear, mucus, squamous intraepithelial lesion (SIL). The Papanicolaou (Pap) test is subject to limitation by obscuring factors that include blood, inflammatory cells, and debris. 1,2 Theoretically, this situation applies to liquid-based Pap technologies as well as the conventional Pap smear. Excessive blood and inflammation are known to interfere with specimen adequacy in some liquid-based Pap testing. 3-7 The 2 commonly used liquid-based cytology technologies, ThinPrep (Hologic, Marlborough, Mass) and BD SurePath (BD Diagnostics TriPath, Burlington, NC), differ in their methods of producing thin-layer Pap slides. 8,9 Some authors, based on their experience with Corresponding author: Douglas Schneider, MD, Department of Pathology, St. Elizabeth s Medical Center, MMR 3, 736 Cambridge Street, Boston, MA 02135; Fax: (617) ; Douglas.Schneider@caritaschristi.org 1 Department of Pathology, St. Elizabeth s Medical Center, Boston, Massachusetts; Massachusetts Received: May 21, 2010; Revised: June 16, 2010; Accepted: June 17, 2010 Published online August 31, 2010 in Wiley Online Library (wileyonlinelibrary.com) DOI: /cncy.20096, wileyonlinelibrary.com 2 Department of Pathology, Tufts Medical Center, Boston, 244 Cancer Cytopathology October 25, 2010
2 Excessive Mucus in Liquid-Based Cytology/Kenyon et al these technologies, have raised questions regarding the relative capacities of ThinPrep and BD SurePath for handling potentially limiting factors, particularly with regard to specimen adequacy. 10,11,12 We have previously shown marked differences in the ability of these 2 technologies to effectively deal with the presence of excessive blood. 13 This study recreates test conditions of excessive mucus and examines the ability of the Thin- Prep and BD SurePath methods to process specimens containing various amounts of cervical mucus. MATERIALS AND METHODS Human cervical epithelial cells were collected by combining the cellular residues from 15 BD SurePath vials after routine Pap test processing was completed. The cells were washed twice in deionized water, and the resulting cell button resuspended in 6 ml of normal saline. This procedure yielded sufficient squamous cells to produce richly cellular SurePath and ThinPrep Pap test slides. The resuspended cells were added to 5 BD SurePath and 5 Thin- Prep liquid Pap test vials in 100 ll aliquots. This procedure was repeated for each of 10 test runs. A collection of pooled cervical mucus was prepared by harvesting mucus from the top of the Prep Stain Density Reagent material in mucus-rich Pap specimens found during the routine BD SurePath cell-enrichment process. The pooled mucus was stable at room temperature for several days, allowing time to collect sufficient amounts for testing. To simulate clinical conditions of excessive mucus, aliquots of the pooled mucus preparation were added to test vials containing the previously dispensed squamous cells in amounts of 250 ll, 500 ll, 1000 ll, and 2000 ll. These volumes were chosen to range from roughly physiological amounts encountered during the BD Surepath cell-enrichment process in mucus-rich specimens to an amount representing an attempt to overwhelm the BD SurePath system with mucus. All test vials were routinely processed on their respective BD SurePath and ThinPrep instruments. For the purposes of this study, coated slides prepared in the laboratory were used for the SurePath tests, rather than the commercially available SurePath Pre- Coat slides. The Pap slides were evaluated for adequacy of cellularity by the first author, who used recommendations provided in The Bethesda System for Reporting Cervical Cytology. 1 The number of squamous cells in high-power fields per slide were counted manually, reading across the horizontal diameter of the test area to include the center, and rendering an average cell count per high power field. The average cell counts resulting from the 2 Pap test systems in 10 test runs were compared. Because of the differing diameters of the BD SurePath and ThinPrep test areas,13 mm and 20 mm, respectively, the Bethesda System Guidelines for Estimating Cellularity of Liquid-based Preparations 1 were used to ensure that the cellularity values presented for BD SurePath and ThinPrep specimens were directly comparable. The Student t test was used in assessing differences in average cellularity between specimens. Endocervical cells were not evaluated because the focus of this study was to determine the effects of mucus on specimen adequacy as determined by the cellularity of the squamous component. RESULTS Representative cytology slide images resulting from the addition of various amounts of mucus are shown for BD SurePath and ThinPrep specimens in Figure 1. The numerical results of the average cell counts from the 10 individual test runs are given in Table 1, with the data presented in graphical form in Figure 2. The BD SurePath test specimens showed no diminishment of cellularity from the addition of any of the aliquots of mucus. Abundant cellularity was observed even in the specimens with the maximum amount of added mucus (2000 ll). In test runs number 3 and number 4, the initial SurePath slides (without added mucus) showed significantly lower cellularity than any of the other initial SurePath test slides. This appeared to be the result of a degree of deficiency in the in-house-prepared slide coating in these 2 instances. Interestingly, most of the BD SurePath specimens showed increases in cellularity with added mucus, presumably because of the release of squamous cells from the mucus (P ¼.01 for mucus aliquots of 1000 ll and 2000 ll). Unexpectedly, we were unable to overwhelm the BD SurePath system with the maximum amount of added mucus. The ThinPrep test specimens invariably showed a loss of cellularity upon the addition of mucus. The addition of the first aliquot of mucus (250 ll) resulted in a 61% average decrease in cellularity (P <.0001). The largest aliquot of mucus (2000 ll) produced Cancer Cytopathology October 25,
3 Original Article FIGURE 1. Gross and microscopic views of BD SurePath (SP) and ThinPrep (TP) slides (left and right columns, respectively) were prepared from pooled cervical epithelial cells with increasing amounts of added mucus. (A) SP slide with no added mucus (10); (B) TP slide with no added mucus (10) showing similar cellularity to slide A; (C) SP slide with 250 ll added mucus (40) showing abundant cellularity; (D) TP slide with 250 ll added mucus (40) showing obscured morphology from entrapment of cells in mucus; (E) SP slide (10) with 500 ll added mucus showing abundant cellularity; (F) TP slide (10) with 500 ll added mucus showing large areas with nearly complete absence of epithelial cells; (G) SP slide (40) with 1000 ll added mucus showing abundant cellularity; (H) TP slide (40) with 1000 ll added mucus showing reduced cellularity and entrapment of cells in mucus; (I) SP slide (10) with 2000 ll added mucus with an ample number of cells; (J) TP slide (10) with 2000 ll added mucus showing entrapment of cells in mucus and large areas with nearly complete absence of cells. 246 Cancer Cytopathology October 25, 2010
4 Excessive Mucus in Liquid-Based Cytology/Kenyon et al Table 1. Comparison of the Average Cell Count per High Power Field (HPF) Adjusted for Test Area Diameter Set Mucus Cells per HPF Added (ll) TP SP an average decrease in cellularity of 87%. ThinPrep slides with added mucus often showed large areas of the filters with nearly complete absence of epithelial cells. Other areas showed compromised morphology from entrapment of cells in mucus (Fig. 1). FIGURE 2. Comparison of SurePath and ThinPrep average cell counts per High Power Field (HPF) show increasing amounts of added mucus (adjusted for test area diameter). The mean and standard deviation of the average cell count per high power field for ThinPrep and SurePath cytology specimens with the addition of 0 ll, 250 ll, 500 ll, 1000 ll, and 2000 ll are plotted. The ThinPrep values were adjusted according to the Bethesda Guidelines for Estimating Cellularity. 4 The data are a compilation of 10 separate experimental runs. DISCUSSION Decreased unsatisfactory rates for the ThinPrep Pap test, as compared with conventional smears, have been reported Conversely, our laboratory experience has shown problems in the uniformity of cell deposition on ThinPrep slides in some conditions, suggesting regional clogging of ThinPrep filter pores with the potential for impacting the detection rate of cervical lesions. Published studies have also indicated the possibility of plugging of the ThinPrep filter membrane resulting in under-represented or unsatisfactory Pap tests. 3,4,18,19 Factors involved in the obstruction of the membrane include blood, inflammation, mucus, cellular debris, and tumor diathesis. Specific to this study, mucus can result in ThinPrep slides with holes or areas devoid of cells. 4 One study looking at reprocessing of unsatisfactory ThinPrep Pap tests found that of the unsatisfactory Pap tests remaining after reprocessing, 20.6% were caused by mucus. 3 Another study reported 37.9% of unsatisfactory ThinPrep Pap tests to be due to mucus before reprocessing procedures were applied. 20 The issue of decreased cell retrieval or uneven cell distribution in ThinPrep Pap tests with excessive mucus, as well as blood and inflammation, was essentially eliminated in our laboratory upon switching to the BD Cancer Cytopathology October 25,
5 Original Article SurePath liquid-based technology. As a result we became curious to see to what extent these 2 technologies differ in their ability to handle mucus-rich specimens. This small study examines this issue using recreated mucus-rich specimens. The results show that specimens processed in the BD SurePath system had effectively no diminution of cellularity with any amount of added mucus. Even when mucus appeared on the slides after amounts were added sufficient to exceed the capacity of the cell enrichment process, there was no compromise of cellular adequacy and no obscuring of cellular morphology. Indeed, cellularity increased in some specimens, presumably from the release of cells from mucus. This finding raises questions about the practice of removing gross mucus from the specimen container before processing, suggesting the possible loss of entrapped cells. In contrast, the ThinPrep specimens invariably showed a loss of cellularity upon the addition of the first aliquot of mucus. The ThinPrep slides exhibited large areas devoid of cells consistent with filter membrane plugging. When mucus was transferred to the slide, those cells trapped in mucus were morphologically compromised. The results are understandable given the differences in technology between the BD SurePath and ThinPrep Pap test systems as posted on company internet sites. 21,22 BD SurePath uses no filters and employs a proprietary cell enrichment process (that) separates and reduces obscuring debris (eg, blood, mucous) and inflammatory cells. The obscuring debris is trapped in a gradient density material that is removed, after which a second centrifugation produces an enriched cell pellet. The cells settle onto coated slides called PreCoat slides. Conversely, the ThinPrep 2000 uses a computerized process and patented membrane technology that controls dispersion, collection, and transfer of diagnostic cells from the sample to the slide. After rotation within the sample vial to separate debris and disperse mucus, a gentle vacuum collects cells on the exterior surface of the Filter membrane. The cells are then transferred by gently pressing the membrane against the microscope slide. It is during the vacuum collection process that the ThinPrep technology appears vulnerable to excess mucus, inflammation, or blood, which can compete with diagnostic cells in the collection process and slow the flow rate, thus terminating collection. Recovery of unsatisfactory ThinPrep specimens has been described using off-label techniques, 3,4,6,20,23 but this entails added expense and labor. Nevertheless, some have found reprocessing of unsatisfactory ThinPrep Pap tests to be a necessity. 4 The issue of unevenly or deficiently coated slides in the SurePath system has been eliminated by the use of company s SurePath PreCoat slides. In our experience at present, the only unsatisfactory BD Sure- Path specimens are those that are truly hypocellular. Further studies appear indicated to determine the best practice for the prevention of potential false-negative results when processing mucus-rich specimens with the ThinPrep methodology. CONFLICT OF INTEREST DISCLOSURES The authors made no disclosures. REFERENCES 1. Birdsong G, Davey D, Darraugh T, Elgert P, Henry M. Specimen Adequacy. In: Solomon D, Nayur R, eds. The Bethesda System for Reporting Cervical Cytology. 2nd ed. New York: Springer; Cox JT. ASCCP practice guidelines: management issues related to quality of the smear. J Low Genit Tract Dis. 1997;1: Bentz JS, Rowe LR, Gopez EV, Marshall CJ. The unsatisfactory ThinPrep Pap test: Missed opportunity for disease detection? Am J Clin Pathol. 2002;117: Chacho MS, Mattie ME, Schwartz PE. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: A comparison. Cancer Cytopathol. 2003;99: Islam S, West AM, Saboorian MJ, Ashfaq R. Cancer. 2004; 102: Belinson JL, Pan QJ, Biscotti C, et al. Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples. Acta Cytol. 2002;46: Song LH, Goh EST, Phang LC, Poh WT, Tay SK. Technical aspect of ThinPrep. Singapore Med J. 2000;41: ThinPrep. (Product Insert). Volume Rev J. Boxborough, MA: Cytyc Corporation; TriPath Imaging I. PrepStain System Product Insert. 2004; Doc No. 61CR000021, Rev Nance KV. Evolution of Pap testing at a community hospital: a ten year experience. Diagn Cytopathol. 2007;35: McGrath CM, Rowe LR, Gupta PK, Bentz JS. Comparison of cytologic preparations in cervicovaginal cytopathology: Conventional smear vs. ThinPrep vs. AutoCyte PREP. Acta Cytol. 2002;46: Cancer Cytopathology October 25, 2010
6 Excessive Mucus in Liquid-Based Cytology/Kenyon et al 12. Fite SK. Impact of converting ThinPrep to SurePath on overall sensitivity and adequacy. Acta Cytol. 2002;46: Sweeney BJ, Haq Z, Happel JF, Weinstein B, Schneider D. Comparison of the effectiveness of 2 liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer. 2006;108: Linder J, Zahniser D. The ThinPrep Pap test. A review of clinical studies. Acta Cytol. 1997;41: Lee KR, Ashfaq R, Birdsong GG, et al. Comparison of conventional Papanicolaou smears and a fluid-based, thinlayer system for cervical cancer screening. Obstet Gynecol. 1997;90: Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol. 1998;42: Wang TY, Chen HS, Yang YC, Tsou MC. Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology. J Formos Med Assoc. 1999;98: Clark SB, Dawson AE. Invasive squamous cell carcinoma in ThinPrep specimens: diagnostic clues in the cellular pattern. Diagn Cytopathol. 2002;26: Dalton P, MacDonald S, Boerner S. Acetic acid recovery of gynecologic liquid-based samples of apparent low squamous cellularity. Acta Cytol. 2006;50: Papillo JL, St John TL, Mahoney PD, et al. Reprocessing of unsatisfactory ThinPrep samples: Procedures to improve specimen adequacy and increase detection of cervical abnormalities. Acta Cytol. 1998;42: BD Surepath Cell Enrichment Process for Liquid-based Pap Test. BD website: sp_cell_enrich.asp. Accessed June 8, The ThinPrep Pap Test: The ThinPrep ThinPrep website: system/thinprep_2000.html. Accessed June 8, Hecht S, Swinehart W, Linder J. Comparison of methods for reprocessing bloody gynecological specimens in Preserv- Cyt solution. Acta Cytol. 2004;48:681. Cancer Cytopathology October 25,
Cervicovaginal Flora Comparison of Conventional Pap Smears and a Liquid-Based Thin-Layer Preparation
Anatomic Pathology / CERVICOVAGINAL FLORA Cervicovaginal Flora Comparison of Conventional Pap Smears and a Liquid-Based Thin-Layer Preparation Hidehiro Takei, MD, 1,2 Bernardo Ruiz, MD, PhD, 2 and John
More informationCervical cytology screening has led to a reduction in cancer mortality
CANCER CYTOPATHOLOGY 105 ThinPrep Pap Test Performance and Biopsy Follow-Up in a University Hospital A. Betts Carpenter, M.D., Ph.D. Diane D. Davey, M.D. Department of Pathology and Laboratory Medicine,
More informationCourse Title: Thin Prep PAP Smears. Number of Clock Hours: 3 Course Title #
Course Title: Thin Prep PAP Smears Number of Clock Hours: 3 Course Title #5240303 Course Introduction There is a new laboratory test that is gaining popularity as a cancer screening tool for cervical cancer.
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Comparison of Performance of Conventional and ThinPrep Gynecologic Preparations in the College of American Pathologists Gynecologic Cytology Program Andrew A. Renshaw,
More informationEffectiveness of the ThinPrep Imaging System:
Effectiveness of the ThinPrep Imaging System: Clinical Experience in a Low Risk Screening Population Jacalyn L. Papillo, B.S., C.T., A.S.C.P., 1 * Timothy L. St. John, B.S., C.T., A.S.C.P., 1 and Gladwyn
More information488 Diagnostic Cytopathology, Vol 35, No 8 ' 2007 WILEY-LISS, INC.
Direct-to-Vial Comparison of a New Liquid-Based Cytology System, Liqui-PREP TM Versus the Conventional Pap Smear Joonseok Park, M.D., 1 * Eun-Ha Jung, M.D., 2 Changok Kim, M.D., 2 and Young Hee Choi, M.D.
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationSPECIMEN PREPARATION AND ADEQUACY OF THE MATERIAL
SPECIMEN PREPARATION AND ADEQUACY OF THE MATERIAL Guido FADDA, MD, MIAC Head, Cytopathology Section Department of Anatomic Pathology and Laboratory Medicine Agostino Gemelli School of Medicine and Hospital
More informationA Comparative Study on the Use of Liquid Based Cytology and Conventional Pap Smear in Cervical Screening
Journal of Medicine and Medical Research Vol. 2(4): 40-50, July, 2014 ISSN: 2350-1502 www.resjournals.org/jmmr A Comparative Study on the Use of Liquid Based Cytology and Conventional Pap Smear in Cervical
More informationMake the BD FocalPoint GS Imaging System your guide in cervical cytology screening. Computer-guided screening
Computer-guided screening Liquid-based cytology Immuno-chemistry Make the BD FocalPoint GS Imaging System your guide in cervical cytology screening Directs your attention to slides most likely to contain
More informationAtypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing
Anatomic Pathology / ATYPICAL GLANDULAR CELLS AND HUMAN PAPILLOMAVIRUS Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing Jeffrey F. Krane,
More informationDepartment of Pathology, Hvidovre Hospital, Copenhagen University Hospital, Copenhagen, Denmark
Comparison of conventional Papanicolaou smear and SurePath Ò liquid-based cytology in the Copenhagen population screening programme for cervical cancer B. Kirschner, K. Simonsen and J. Junge Department
More informationAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia
DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester
More informationCan LBC Completely Replace Conventional Pap Smear in Developing Countries
The Journal of Obstetrics and Gynecology of India (January February 2019) 69(1):69 76 https://doi.org/10.1007/s13224-018-1-7 ORIGINAL ARTICLE Can LBC Completely Replace Conventional Pap Smear in Developing
More informationInstructions For Use
MAN-02624-001 Rev. 004 page 1 of 15 Instructions For Use INTENDED USE The ThinPrep 2000 System is intended as a replacement for the conventional method of Pap smear preparation for use in screening for
More informationComparison of Unsatisfactory Samples from Conventional Smear versus Liquid-Based Cytology in Uterine Cervical Cancer Screening Test
Journal of Pathology and Translational Medicine 2017; 51: 314-319 ORIGINAL ARTICLE Comparison of Unsatisfactory Samples from Conventional Smear versus Liquid-Based Cytology in Uterine Cervical Cancer Screening
More informationHPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China
2436 Ivyspring International Publisher Research Paper Journal of Cancer 2017; 8(13): 2436-2441. doi: 10.7150/jca.19421 HPV test results and histological follow-up results of patients with LSIL Cervical
More informationComparison of ThinPrep and Conventional Preparations for Peritoneal and Pleural Cytology Smears
Annual Research & Review in Biology 4(20): 3139-3149, 2014 SCIENCEDOMAIN international www.sciencedomain.org Comparison of ThinPrep and Conventional Preparations for Peritoneal and Pleural Cytology Smears
More informationUnsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
Open Access To cite: Fontaine D, Narine N, Naugler C. Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis. BMJ Open 2012;2:e000847.
More informationNILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA
NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA Focused Rescreening Prior to Report Issuance, An Enhanced Quality Control Measure Karen Cormier, CT(ASCP), 1 Michael
More informationThe comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting
BJOG: an International Journal of Obstetrics and Gynaecology November 2005, Vol. 112, pp. 1542 1546 DOI: 10.1111/j.1471-0528.2005.00699.x The comparative diagnostic accuracy of conventional and liquid-based
More informationComparison of ThinPrep and TriPath PREP Liquid-Based Preparations in Nongynecologic Specimens: A Pilot Study
CURRENT ISSUES Comparison of ThinPrep and TriPath PREP Liquid-Based Preparations in Nongynecologic Specimens: A Pilot Study Claire W. Michael, M.D., 1 * James McConnel, M.D., 2 James Pecott, C.T. (A.S.C.P.),
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006 Galen M. Eversole, MD; Ann T. Moriarty,
More informationMaterials and Methods
Accuracy of Diagnosis of Atypical Glandular Cells Conventional and ThinPrep Reena Ramsaroop, M.B., Ch.B., F.F.Path., Ph.D.* and Ien Chu, N.Z.I.M.L.T., Q.T.A., Q.T.O. The incidence of glandular cervical
More informationHigh-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer
103 Ivyspring International Publisher Research Paper International Journal of Medical Sciences 2012; 9(1):103-107 High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics,
More informationSara J. Bernstein, MD, Luis Sanchez-Ramos, MD, and Boniface Ndubisi, MD Jacksonville, Fla
Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy Sara J. Bernstein, MD, Luis Sanchez-Ramos,
More informationComparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears
The Korean Journal of Pathology 2012; 46: 365-369 ORIGINAL ARTICLE Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears Jung Dal Lee 1,2
More informationAssisted Primary Screening Using the Automated ThinPrep Imaging System
Anatomic Pathology / THINPREP AUTOMATED CERVICAL SCREENING Assisted Primary Screening Using the Automated ThinPrep Imaging System Charles V. Biscotti, MD, 1 Andrea E. Dawson, MD, 1 Bruce Dziura, MD, 2
More informationCytology of gastrointestinal (GI) samples has a high
Comparison of ThinPrep Preparations to Other Preparation Types in Gastrointestinal Cytology Observations From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology
More informationORIGINAL ARTICLE. Key Words: effusion; body fluid; cytology; CellprepPlusVR ; ThinPrepVR
ORIGINAL ARTICLE Comparison of Diagnostic Accuracy Between CellprepPlusVR and Liquid-Based Preparations in Effusion Cytology Yong-Moon Lee, M.D., 1 Ji-Yong Hwang, 1 Seung-Myoung Son, M.D., 1 Song-Yi Choi,
More informationPredictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases
Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases Can Potential Clues of Malignancy Be Identified? Mohammad Jaragh, MD 1 ; V. Bessie Carydis, MMedSci (Cytol) 1 ; Christina
More informationASCCP Patient Management Guidelines * Pap Test Specimen Adequacy and Quality Indicators
Anatomic Pathology / PAP SPECIMEN ADEQUACY GUIDELINES ASCCP Patient Management Guidelines * Pap Test Specimen Adequacy and Quality Indicators Diane D. Davey, MD, Chair, 1 R. Marshall Austin, MD, PhD, 2
More informationAnatomic Pathology / CONVENTIONAL VS AUTOMATED PAPANICOLAOU SMEAR SCREENING
Anatomic Pathology / CONVENTIONAL VS AUTOMATED PAPANICOLAOU SMEAR SCREENING Can Technology Expedite the Cervical Cancer Screening Process? A Hong Kong Experience Using the AutoPap Primary Screening System
More informationHuman Papillomavirus Testing Using Hybrid Capture II With SurePath Collection
468 Human Papillomavirus Testing Using Hybrid Capture II With SurePath Collection Initial Evaluation and Longitudinal Data Provide Clinical Validation for This Method Vincent Ko, MD Rosemary H. Tambouret,
More informationInterpretation guide. Abnormal cytology can t hide anymore
Interpretation guide Abnormal cytology can t hide anymore Unique dual-biomarker technology makes you certain about the presence of transforming HPV infection. The science that creates certainty. Table
More informationLong-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance
Anatomic Pathology / LONG-TERM OUTCOME WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance Stephen
More informationThinPrep 5000 Processor Instructions for Use
5000 Processor Instructions for Use MAN-04008-001 Rev. 001 Page 1 of 27 INTENDED USE The 5000 processor is intended as a replacement for the conventional method of Pap smear preparation for use in screening
More informationIn 1988, The Bethesda System (TBS) introduced the phrase atypical
CANCER CYTOPATHOLOGY 93 Should the Cytologic Diagnosis of Atypical Squamous Cells of Undetermined Significance Be Qualified? An Assessment Including Comparison between Conventional and Liquid-Based Technologies
More informationSALINA PATHOLOGY LABORATORY
TABLE OF CONTENTS ================================================= REQUISITION... 2 SPECIMEN LABELING... 2 PAP SMEAR SPECIMEN COLLECTION... 3 Patient Preparation... 3 Sample Collection... 3 Placement
More informationThe Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015
HARVARD MEDICAL SCHOOL The Bethesda System: Updates for 2015 6th Cytopathology Congress Bursa, Turkey October 14, 2015 David C. Wilbur, M.D. Dept. of Pathology Massachusetts General Hospital DISCLOSURES
More informationCytyc Corporation - Case Presentation Archive - July 2002
ThinPrep Pap Test History: 34 Year Old Female LMP: Day 20 Specimen Type: Cervical/Vaginal Case provided by Mark Tulecke, M.D. and Gabrielle Trawinski CT (ASCP), Mount Auburn Hospital, Cambridge, Massachusetts.
More informationEvaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear
The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationHPV Testing & Cervical Cancer Screening:
HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success
More informationAgreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology
Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Andrew M. Quinn, MD 1 ; Abu T. Minhajuddin, PhD 2 ; Linda S. Hynan, PhD
More informationCervical disease screening and detection: emerging techniques in molecular diagnostic assays
Cervical disease screening and detection: emerging techniques in molecular diagnostic assays By Dorothy L. Rosenthal, MD, FIAC Current techniques in cervical disease detection CONTINUING EDUCATION To earn
More informationThe Korean Journal of Cytopathology 13(1): 14-20, 2002
13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous
More informationdifficult and may not be practical. Nevertheless, the performance characteristics of rapid screening have not been completely characterized.
Anatomic Pathology / PERFORMANCE CHARACTERISTICS OF RAPID PRESCREENING Performance Characteristics of Rapid (0-Second) Prescreening Implications for Calculating the False-Negative Rate and Comparison With
More informationSpecimen Collection & Handling Instructions HUMAN PAPILLOMAVIRUS (HPV) COLLECTION IN SUREPATH
HUMAN PAPILLOMAVIRUS (HPV) COLLECTION IN SUREPATH NOTE: HPV TESTING IS NOT FUNDED BY MOHLTC Patient payment of $90.00 is required HPV testing can be used to refine the management of women over the age
More informationPAP SMEAR and BD SurePath TM Tests
PAP SMEAR and BD SurePath TM Tests What is a Pap smear? A Pap smear is a simple procedure in which cells are removed from the lower end of the womb (cervix) during an internal examination of the vagina.
More informationThe AutoPap Primary Screening System (APSS; Tripath Imaging,
CANCER CYTOPATHOLOGY 129 A Feasibility Study of the Use of the AutoPap Screening System as a Primary Screening and Location-Guided Rescreening Device Massimo Confortini, M.D. 1 Lucia Bonardi, M.D. 1 Paolo
More informationCytoCoreinc. 414 North Orleans St. Suite 502 Chicago, IL p: cytocoreinc.com. core solutions for innovative care.
CytoCore, Inc. is a biomolecular diagnostics company engaged in the design, development and commercialization of cost-effective screening systems for the early detection of cancer and cancer-related diseases.
More informationPAP. Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) YEAR END SUMMARY REPORT. Anatomic Pathology Programs
2005 PAP Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) Surveys and Educational Anatomic Pathology Programs YEAR END SUMMARY REPORT 2005 College of American Pathologists. The
More informationSuthi Sangkarat, Somsak Laiwejpithaya, Manee Rattanachaiyanont, Pattama Chaopotong*, Mongkol Benjapibal, Weerasak Wongtiraporn, Sujera Laiwejpithaya
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.5.2051 RESEARCH ARTICLE Performance of Siriraj Liquid-Based Cytology: a Single Center Report Concerning over 100,000 Samples Suthi Sangkarat, Somsak Laiwejpithaya,
More informationNegative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?
Anatomic Pathology / FALSE-NEGATIVE HISTOLOGIC FINDINGS Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?
More informationEditorial Process: Submission:11/02/2017 Acceptance:05/19/2018
RESEARCH ARTICLE Editorial Process: Submission:11/02/2017 Acceptance:05/19/2018 Comparative Analysis of Modified Liquid-Based Cytology and CytoRich Red Preparation in Assessment of Serous Effusion for
More informationThe Biology of HPV Infection and Cervical Cancer
The Biology of HPV Infection and Cervical Cancer Kaitlin Sundling, M.D., Ph.D. Clinical Instructor Faculty Director, Cytotechnology Program Wisconsin State Laboratory of Hygiene and University of Wisconsin
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationDETECTING CELLS USING IMAGE SEGMENTATION OF THE CERVICAL CANCER IMAGES TAKEN FROM SCANNING ELECTRON MICROSCOPE
DETECTING CELLS USING IMAGE SEGMENTATION OF THE CERVICAL CANCER IMAGES TAKEN FROM SCANNING ELECTRON MICROSCOPE Sevcan AYTAÇ KORKMAZ Fırat University, Department of Electronic Technology, Elazığ- TURKEY
More informationClinical utility of Liqui-PREP cytology system for primary cervical cancer screening in a large urban hospital setting in China
Original Article Clinical utility of Liqui-PREP cytology system for primary cervical cancer screening in a large urban hospital setting in China ABSTRACT Background: Liquid based cytology (LBC) has been
More informationCytology Automation: An Overview
CE Update [cytology generalist] Cytology Automation: An Overview Philip T. Valente, MD, H. Daniel Schantz, MBA, CT(ASCP) Department of Pathology, The University of Texas Health Science Center at San Antonio,
More informationRevisions ECO # W W W W
Revisions BALTSO0191 Version 7.0 Template 4 Rev from Rev to ECO # 02 03 6678-13 NOTES: 1. BD Catalog Number: 443327 2. Blank (Sheet) Size: Length: 11 Width: 8.5 3. Number of Pages: 8 Number of Sheets:
More informationMEDICAL POLICY. SUBJECT: CERVICAL CANCER SCREENING and HUMAN PAPILLOMA VIRUS (HPV) TESTING
MEDICAL POLICY SUBJECT: CERVICAL CANCER SCREENING PAGE: 1 OF: 12 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationCervical Cancer Prevention by Liquid-Based Cytology in a Low-Resource Setting
Cervical Cancer Prevention by Liquid-Based Cytology in a Low-Resource Setting 7 Mongkol Benjapibal and Somsak Laiwejpithaya Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital,
More informationFine-needle aspiration biopsy (FNAB) of the thyroid gland currently
CANCER CYTOPATHOLOGY 179 Cytologic Artifacts and Pitfalls of Thyroid Fine-Needle Aspiration Using ThinPrep A Comparative Retrospective Review Alaa M. Afify, M.D. Jing Liu, M.D. Basim M. Al-Khafaji, M.D.
More informationCervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens
Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens 3 Christine Bergeron, MD, PhD Introduction Carcinoma of the cervix is a slow growing cancer, which is preceded by precancerous
More information(Pap) results, ie, abnormal squamous cells of undetermined significance (ASCUS). According to
The Role of Human Papillomavirus Type 16/18 Genotyping in Predicting High-Grade Cervical/Vaginal Intraepithelial Neoplasm in Women With Mildly Abnormal Papanicolaou Results Ming Guo, MD 1 ; Yun Gong, MD
More informationBiomed Environ Sci, 2015; 28(1): 80-84
80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* YANG Yi1, LANG Jing He1, WANG You Fang1, CHENG
More informationThe diagnostic category of atypical squamous cells of undetermined
100 CANCER CYTOPATHOLOGY Significance of a Diagnosis of Atypical Squamous Cells of Undetermined Significance for Papanicolaou Smears in Perimenopausal and Postmenopausal Women Jeffrey T. Keating, M.D.
More informationWorkshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation
Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital Cervical
More informationA Cytologic/Histologic Review of 367 Cases. Original Article. Cancer Cytopathology August 25,
Correlation Between Hybrid Capture II High-Risk Human Papillomavirus DNA Test Chemiluminescence Intensity From Cervical Samples With Follow-Up Histologic Results A Cytologic/Histologic Review of 367 Cases
More informationReporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001
Anatomic Pathology / THE EFFECT OF BETHESDA 2001 ON REPORTING OF ENDOMETRIAL CELLS Reporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001 Aylin Simsir,
More informationCervical Cancer : Pap smear
Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective
More informationApplication of Chromogenic In Situ Hybridization (CISH) for Human Papillomavirus (HPV) Genotyping
Research Article imedpub Journals http://www.imedpub.com Archives in Cancer Research Vol. 4 No. 2:70 Application of Chromogenic In Situ Hybridization (CISH) for Human Papillomavirus (HPV) Genotyping Ekaterina
More informationStudy of Cervical Pap Smears in a Tertiary Hospital
250 Original Study Study of Cervical Pap Smears in a Tertiary Hospital Sunita A. Bamanikar, Professor, Department of Pathology, Dadaso S. Baravkar, Resident Pathologist, Department of Pathology, Shirish
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationModernization of your cytology laboratory and Co-Testing Approach for Cervical Screening
Modernization of your cytology laboratory and Co-Testing Approach for Cervical Screening 2 nd ESPC & 27 th IAP-AD annual meeting Dubai - UAE Mousa Al-Abbadi, MD, FIAC, FCAP, CPHQ, CPE Professor of Pathology
More informationCervical acid phosphatase: a new biomarker of cervical dysplasia
Original article UDC: 618.146-006:616-071 Archive of Oncology 2003;11(4):243-7. Cervical acid phosphatase: a new biomarker of cervical dysplasia Olivera MARKOVIÆ Nenad MARKOVIÆ BioSciCon, INC., ROCKVILLE,
More informationDetecting High-Grade Cervical Disease on ASC-H Cytology. Role of BD ProEx C and Digene Hybrid Capture II HPV DNA Testing
Anatomic Pathology / BD ProEx C Use in ASC-H Cy t o l o g y Detecting High-Grade Cervical Disease on ASC-H Cytology Role of BD ProEx C and Digene Hybrid Capture II HPV DNA Testing Momin T. Siddiqui, MD,
More informationWhat is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
More informationCytyc Corporation - Case Presentation Archive - June 2003
ThinPrep General Cytology History: Asymptomatic 35 Year Old Male Specimen type: Anal Cytology - This specimen was collected using a Dacron swab under proctoscopic visualization. This case was provided
More informationMorphologic and Immunocytochemical Performances of Effusion Cell Blocks Prepared Using 3 Different Methods
Anatomic Pathology / Performance of Different Cell Block Preparation Techniques Morphologic and Immunocytochemical Performances of Effusion Cell Blocks Prepared Using 3 Different Methods Xin Jing, MD,
More informationOutcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure
The Korean Journal of Pathology 2012; 46: 359-364 ORIGINAL ARTICLE Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure Joon Seon Song Ilseon
More informationIdentification of cervicovaginal flora in liquid-based Surepath. Results of rodeo study.
Identification of cervicovaginal flora in liquid-based Surepath. Results of rodeo study. Stein MD 1, Fregnani JH 1,2, Scapulatempo C 1 and Longatto-Filho A 2,3,4,5 1 Barretos Cancer Hospital, Pio XII Foundation,
More informationA Comparison Between ThinPrep Monolayer and Cytospin Cytology for the Detection of Bladder Cancer
www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.6.390 Original Article - Urological Oncology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.6.390&domain=pdf&date_stamp=2014-06-16
More informationAbnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing
280 Abnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing Giovanni Negri, MD Bettina Rigo, BS Fabio Vittadello, ScD Christine Mian, ScD Eduard Egarter-Vigl, MD Department of Pathology,
More informationCervical Precancer: Evaluation and Management
TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of
More informationPushing the Boundaries of the Lab Diagnosis in Asia
Pushing the Boundaries of the Lab Diagnosis in Asia Diana Lim MBBS, FRCPA, FRCPath (UK) Senior Consultant National University Health System and National University of Singapore Department of Pathology
More informationA COMPARISON OF MODIFIED AND STANDARD PAPANICOLAOU STAINING METHODS IN THE ASSESSMENT OF CERVICAL SMEARS AT KENYATTA NATIONAL HOSPITAL
July 211 Ea s t Af r i c a n Me d i c a l Jo u r n a l 244 East African Medical Journal Vol 88 No 7 July 211 A COMPARISON OF MODIFIED AND STANDARD PAPANICOLAOU STAINING METHODS IN THE ASSESSMENT OF CERVICAL
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationInternational Journal of Biological & Medical Research
Int J Biol Med Res. ; 2(3): 757-761 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 3, July BioMedSciDirect Publications Contents lists available at BioMedSciDirect Publications International
More informationComparison between Siriraj Liquid-based and Conventional Cytology for Detection of Abnormal Cervicovaginal Smears: A Split-sample Study
Comparison between Liquid-based and Conventional Cytology in Thailand RESEARCH COMMUNICATION Comparison between Siriraj Liquid-based and Conventional Cytology for Detection of Abnormal Cervicovaginal Smears:
More informationImproved Detection of Cervical Cancer and High Grade Neoplastic Lesions by a Combination of Conventional Cytology and DNA Automated Image Cytometer
Journal of Cancer Therapy, 2010, 1, 47-51 doi:10.4236/jct.2010.12008 Published Online June 2010 (http://www.scirp.org/journal/jct) 47 Improved Detection of Cervical Cancer and High Grade Neoplastic Lesions
More informationidc 20 AUTOMATED LIQUID-BASED CYTOLOGY SLIDE PREPARATION SYSTEM
idc 20 AUTOMATED LIQUID-BASED CYTOLOGY SLIDE PREPARATION SYSTEM ilsa : 16 rue de la Comtesse - 25640 MARCHAUX - FRANCE Phone : +33 (0) 381 579 034 Web : www.ilsa-france.com Email : contact@ilsa-france.com
More informationBackground to the Thyroid Nodule
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital THYROID FNA: PART I Background to the
More informationThe application of cytology in urological diseases
Voided urine cytology The application of cytology in urological diseases Dr Ashish Chandra FRCPath DipRCPath (Cytol) Guy s & St Thomas NHSfT London Detection of high grade urothelial carcinoma Monitoring
More informationQuarterly laboratory and pathology update from Legacy Laboratory Services in collaboration with Cascade Pathology
Legacy LabAdvisor Quarterly laboratory and pathology update from Legacy Laboratory Services in collaboration with Cascade Pathology Edition 3 Inside this issue New Testing Developments.... 2 Test Algorithm...
More informationCytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
More informationHPV-Negative Results in Women Developing Cervical Cancer: Implications for Cervical Screening Options
HPV-Negative Results in Women Developing Cervical Cancer: Implications for Cervical Screening Options R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center (UPMC) (raustin@magee.edu)
More informationCytology and Surgical Pathology of Gynecologic Neoplasms
Cytology and Surgical Pathology of Gynecologic Neoplasms Current Clinical Pathology ANTONIO GIORDANO, MD, PHD SERIES EDITOR For further titles published in this series, go to http://www.springer.com/springer/series/7632
More information